NYSEArca - Delayed Quote USD

Virtus LifeSci Biotech Products ETF (BBP)

52.29 -0.10 (-0.20%)
At close: April 24 at 9:30 AM EDT
Loading Chart for BBP
DELL
  • Previous Close 52.39
  • Open 52.63
  • Bid --
  • Ask --
  • Day's Range 52.29 - 52.63
  • 52 Week Range 45.00 - 63.25
  • Volume 351
  • Avg. Volume 3,048
  • Net Assets 19.84M
  • NAV 52.27
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return -9.99%
  • Beta (5Y Monthly) 0.65
  • Expense Ratio (net) 0.79%

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

Virtus

Fund Family

Health

Fund Category

19.84M

Net Assets

2014-12-16

Inception Date

Performance Overview: BBP

Trailing returns as of 4/24/2024. Category is Health.

YTD Return

BBP
9.99%
Category
6.33%
 

1-Year Return

BBP
1.70%
Category
11.04%
 

3-Year Return

BBP
0.82%
Category
0.38%
 

People Also Watch

Holdings: BBP

Top 10 Holdings (27.28% of Total Assets)

SymbolCompany% Assets
TARS
Tarsus Pharmaceuticals, Inc. 3.65%
LXRX
Lexicon Pharmaceuticals, Inc. 3.54%
ADMA
ADMA Biologics, Inc. 3.13%
SWTX
SpringWorks Therapeutics, Inc. 2.72%
SRPT
Sarepta Therapeutics, Inc. 2.63%
ASND
Ascendis Pharma A/S 2.41%
AGIO
Agios Pharmaceuticals, Inc. 2.41%
MRNA
Moderna, Inc. 2.38%
KNSA
Kiniksa Pharmaceuticals, Ltd. 2.22%
NBIX
Neurocrine Biosciences, Inc. 2.18%

Sector Weightings

SectorBBP
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

Research Reports: BBP

  • ERF: What does Argus have to say about ERF?

    ENERPLUS CORP has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • Analyst Report: Netflix Inc

    Netflix is a video-on-demand distributor of movies and television shows over the internet worldwide (except China and a few other countries). Subscribers have access to the Netflix content library for a fixed monthly subscription fee. The company offers several service tiers, including a discount advertising-supported service. Netflix derives 59% of its revenue from outside the U.S.

    Rating
    Price Target
     
  • Analyst Report: Netflix, Inc.

    Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

    Rating
    Price Target
     
  • Analyst Report: Netflix, Inc.

    Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

    Rating
    Price Target
     

Related Tickers